ResMed
682 hedge funds and large institutions have $23.6B invested in ResMed in 2022 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 227 increasing their positions, 277 reducing their positions, and 89 closing their positions.
38% more call options, than puts
Call options by funds: $81.5M | Put options by funds: $58.9M
1.74% more ownership
Funds ownership: 64.96% → 66.7% (+1.7%)
0% more funds holding in top 10
Funds holding in top 10: 10 → 10 (0)
4% less capital invested
Capital invested by funds: $24.6B → $23.6B (-$955M)
6% less funds holding
Funds holding: 723 → 682 (-41)
18% less repeat investments, than reductions
Existing positions increased: 227 | Existing positions reduced: 277
37% less first-time investments, than exits
New positions opened: 56 | Existing positions closed: 89
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$555M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$212M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$123M |
| 4 |
ATO
Alecta Tjanstepension Omsesidigt
Stockholm,
Sweden
|
+$104M |
| 5 |
JP Morgan Chase
New York
|
+$92.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WCM Investment Management
Laguna Beach,
California
|
-$105M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$65.8M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$57.4M |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$52.4M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$52.3M |
RMD Hedge Fund Activity: Q1 2022 in Review
682 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q1 2022, worth a combined $23.6B — down 3.9% from $24.6B a quarter earlier.
Sellers outnumbered buyers: 89 funds closed out of RMD and 56 opened new positions — a net loss of 33 holders — while 277 trimmed existing stakes and 227 added.
The largest buyer was Fidelity Investments, adding an estimated $555M. The largest seller was WCM Investment Management, cutting an estimated $105M.
- 682 institutional investors held ResMed (RMD) as of Q1 2022, down from 723 in Q4 2021.
- Funds reported $23.6B of ResMed stock for Q1 2022, down 3.9% quarter-over-quarter.
- 56 funds opened new ResMed positions in Q1 2022 and 89 closed out, a net change of -33 holders.
- The largest ResMed buyer in Q1 2022 was Fidelity Investments, an estimated $555M added.
- The largest ResMed seller in Q1 2022 was WCM Investment Management, an estimated $105M sold.
Based on aggregated 13F filings for Q1 2022.